[125I]β-CIT-FE and [125I]β-CIT-FP are superior to [125I]β- CIT for dopamine transporter visualization: Autoradiographic evaluation in the human brain

Nuclear Medicine and Biology

Volumn 24, Issue 7, 1997, Pages 629-634

  Günther, Ilonka ^a,b   Hall, Håkan ^a   Halldin, Christer ^a   Swahn, Carl Gunnar ^a   Farde, Lars ^a   Sedvall, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

CIT; CIT FP; CIT FE; Autoradiography; Dopamine transporters; Human brain

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CITALOPRAM; DESIPRAMINE; DOPAMINE TRANSPORTER; ECGONINE METHYL ESTER; IODINE 125; MAZINDOL; MONOAMINE; RADIOLIGAND; SEROTONIN; VANOXERINE; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; CARRIER PROTEIN; COCAINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; MEMBRANE PROTEIN; N (2 FLUOROETHYL) 2 CARBOMETHOXY 3 (4 IODOPHENYL)NORTROPANE; N-(2-FLUOROETHYL)-2-CARBOMETHOXY-3-(4-IODOPHENYL)NORTROPANE; NERVE PROTEIN; NORTROPANE DERIVATIVE; RADIOACTIVE IODINE; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN; TROPANE DERIVATIVE;

ADULT; ALKYLATION; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FLUORINATION; HEMISPHERE; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LIGAND BINDING; MALE; NEOCORTEX; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS; BRAIN; BRAIN LEVEL; CHEMISTRY; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

AUTORADIOGRAPHY; BRAIN; BRAIN CHEMISTRY; CARRIER PROTEINS; COCAINE; CONTRAST MEDIA; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NORTROPANES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 0030608983     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00081-4     Document Type: Article

References (39)

1. Abi-Dargham A., Gandelman M. S., DeErausquin G. A., Zea-Ponce Y., Zoghbi S. S., Baldwin R. M. et al. (1996) SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of β-CIT. J. Nucl. Med. 37, 1129-1133.
2. Alburges M. E., Narang N. and Wamsley J. K. (1993) Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14, 314-323.
3. Allard P. (1995) Questions about the dopamine terminals in human frontal cortex - Reply. J. Neurochem. 64, 1902-1903.
4. 3H]GBR-12935 binding to dopamine uptake sites in rat striatum. Neuropsychobiology 23, 177-181.
5. Allard P. O., Rinne J. and Marcusson J. O. (1994) Dopamine uptake sites in Parkinsons disease and in dementia of the Alzheimer type. Brain Res. 637, 262-266.
6. 3H]WIN 35,428 binding in the caudate nucleus of the rabbit -evidence for a single site on the dopamine transporter. J. Pharmacol. Exp. Ther. 273, 435-444.
7. Andersen P. H. (1989) The dopamine inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493-504.
8. 3H]GBR 12935 binding in vivo in mouse brain: Labelling of a piperazine acceptor site. Eur. J. Pharmacol. 144, 1-6.
9. 123I]N-omega-fluoroalkyl-2 beta-carboxy-3 beta-(4-iodophenyl)-nortropane esters in baboons. Nucl. Med. Biol. 22, 211-219.
10. Bannon M. J., Granneman J. G. and Kapatos G. (1995) The dopamine transporter: Potential involvement in neuropsychiatric disorders. In: Psychopharmacology : The fourth generation of progress (Edited by F. E. Bloom and D. J. Kupfer), Raven Press, New York, pp. 179-188.
11. Boja J. W., Cadet J. L., Kopajtic T. A., Lever J., Seltzman H. H., Wyrick C. D. et al. (1995) Selective labeling of the dopamine transporter by the high affinity ligand 3-beta-(4-[I-125]iodophenyl)tropane-2-beta-carboxylic acid isopropyl ester. Mol. Pharmacol. 47, 779-786.
12. 3H]paroxetine. Neuroscience 27, 473-496.
13. Farde L. and Hall H. (1992) Positron emission tomography - examination of chemical transmission in the living human brain: Development of radioligands. Arzneim.-Forsch./Drug Res. 42-41, 260-264.
14. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16, 93-103.
15. 11C]WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol. 34, 423-431.
16. 125I]epidepride. Synapse 23, 115-123.
17. 2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11, 245-256.
18. 11C]β-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse 22, 386-390.
19. 3H]GBR-12935 binding sites in human striatal membranes: Binding characteristics and changes in patkinsonians and schizophrenics. Jpn. J. Pharmacol. 47, 237-243.
20. Hyttel J. (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6, 277-295.
21. 123I]CIT. Eur. J. Pharmacol. 200, 369-370.
22. Innis R. B., Seibyl J. P., Scanley B. E., Laruelle M., Abi-Dargham A., Wallace E. et al. ( 1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc. Natl. Acad. Sci. USA 90, 11965-11969.
23. Janowsky D. S. and Byerley B. (1984) Desipramine: An overview. J. Clin. Psychiatry 45, 3-9.
24. Kuikka J. T., Bergström K. A., Ahonen A., Hiltunen J., Haukka J., Lansimies E. et al. (1995) Comparison of iodine-123 labelled 2β-carbomethoxy-3β-(4-iodophenyl)tropane and 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Eur. J. Nucl. Med. 22, 356-360.
25. Kung M. P., Essman W. D., Frederick D., Meegalla S., Goodman M., Mu M. et al. (1995) IPT: A novel iodinated ligand for the CNS dopamine transporter. Synapse 20, 316-324.
26. 123I]β-CIT - pharmacological characterization of brain uptake in nonhuman primates. Synapse 13, 295-309.
27. 3H]paroxetine binding, a marker of serotonin uptake sites. Biol. Psychiatry 24, 299-309.
28. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J. Cereb. Blood Flow Metab. 14, 982-994.
29. 125I]RTI-121 binding sites in human striatum and medial temporal lobe. J. Pharmacol. Exp. Ther. 274, 1473-1483.
30. 11C]β-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: Preparation, autoradiography, metabolite studies and positron emission tomography examinations. Nucl. Med. Biol. 22, 905-913.
31. 3H]GBR-12935 binding to dopamine uptake sites in the human brain. Brain Res. 457, 122-129.
32. Milne R. J. and Goa K. L. (1991) Citalopram: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41, 450-477.
33. 11C]β-CIT, a cocaine analogue: Preparation, autoradiography and preliminary PET investigations. Nucl. Med. Biol. 20, 249-255.
34. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)-tropane: High-affinity SPECT radiotracer of monoamine reuptake sites in brain. J. Med. Chem. 34, 3144-3146.
35. Neumeyer J. L., Wang S. Y., Gao Y. G., Milius R. A., Kula N. S., Campbell A. et al. (1994) N-ω-fluoroalkyl analogs of (1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane (β-CIT): Radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters. J. Med. Chem. 37, 1558-1561.
36. 11C-Ro 15-1788 binding to human brain sections. J. Neurosci. Methods 36, 53-61.
37. 125I]RTI-55 associated with the 5-HT transporter in rat brain membranes. J. Pharmacol. Exp. Ther. 273, 213-222.
38. 125I]RTI-55-in vitro binding and autoradiographic characterization. J. Neurochem. 62, 549-556.
39. 125I-labelled β-CIT and its ω-fluoroalkyl analogues β-CIT-FE and β-CIT-FP, including synthesis of precursors. J. Label. Comp. Radiopharm. 38, 675-685.